Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Tom Holvoet

Publications & Research Data

Awards & Distinctions

29 Results

2025

Post-discharge outcomes of elderly patients hospitalized for inflammatory bowel disease flare complicated by Clostridioides difficile infection

Idan GorenOrtal Fallek BoldesTomer BoldesOleg KnyazevAnna KagramanovaJimmy K LimdiEleanor LiuKarishma Sethi-AroraTom HolvoetPiotr Eder et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

Ustekinumab in ulcerative colitis : a real-life effectiveness study across multiple Belgian centers (SULTAN)

Tom HolvoetMarie TruyensCatherine ReenaersFilip BaertStijn Vanden BrandenAnneline CremerLieven PouillonPieter DewintWouter Van MoerkerckeJean-François Rahier et al.

A1 Journal Article in JOURNAL OF CLINICAL MEDICINE

2024

Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study

Tom HolvoetMarie TruyensCara De GalanHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui-AmezagaRocio Ferreiro-Iglesias et al.

A1 Journal Article in JOURNAL OF CLINICAL MEDICINE

2022

Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial

Marie TruyensTriana Lobatón OrtegaMarc FerrantePeter BossuytSéverine VermeireLieven PouillonPieter DewintAnneline CremerHarald PeetersGuy Lambrecht et al.

A1 Journal Article in GASTROENTEROLOGY

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study

Cara De GalanMarie TruyensHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui AmezagaRocio Ferreiro- IglesiasTom Holvoet et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

2021

Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating : short- and long-term results from a placebo-controlled randomized trial

Tom HolvoetMarie JoossensJorge F. Vazquez-CastellanosEvelien ChristiaensLander HeyerickJerina BoelensBruno VerhasseltHans Van VlierbergheMartine De VosJeroen Raes et al.

A1 Journal Article in GASTROENTEROLOGY

Optimal management of acute severe ulcerative colitis (ASUC) : challenges and solutions

Tom HolvoetTriana Lobatón OrtegaPieter Hindryckx

A2 Journal Article in CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY

2020

Vasomodulators and liver transplantation for portopulmonary hypertension : evidence from a systematic review and meta-analysis

Rebecca DerooEric TrepoTom HolvoetMichel De PauwAnja GeertsXavier VerhelstIsabelle ColleHans Van VlierbergheMichael B. FallonSarah Raevens

A1 Journal Article in HEPATOLOGY

2019

Oral vasodilator treatment and liver transplantation for portopulmonary hypertension : systematic review and meta-analysis of hemodynamic response and prognosis

Rebecca DerooMichel De PauwEric TrepoTom HolvoetAnja GeertsXavier VerhelstIsabelle ColleHans Van VlierbergheSarah Raevens

2018

Fecal microbiota transplantation in irritable bowel syndrome with predominant abdominal bloating : results from a double blind, placebo-controlled clinical trial

Tom HolvoetMarie JoossensJerina BoelensEvelien ChristiaensLander HeyerickBruno VerhasseltMartine De VosPieter HindryckxJeroen RaesDanny De Looze

New insights into the treatment and pathophysiology of fibrostenotic Crohn’s Disease

Tom HolvoetMartine De VosDebby Laukens

2017

Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating

Tom HolvoetMarie JoossensJun WangJerina BoelensBruno VerhasseltDebby LaukensHans Van VlierberghePieter HindryckxMartine De VosDanny De Looze et al.

A1 Journal Article in GUT

Early fibrostenosis in Crohn's disease is associated with multiple susceptibility loci on Immunochip analysis

Tom HolvoetPeter BossuytIsabelle CleynenIsabelle De KockPieter HindryckxSeverine VermeireDebby LaukensMartine De Vos

Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

Sophie Van WeldenMartine De VosBen WielockxSimon TavernierMelissa DullaersSara NeytBenedicte DescampsLindsey DevisscherSarah DevrieseLien Van den Bossche et al.

A1 Journal Article in JOURNAL OF PATHOLOGY

T84 monolayers are superior to Caco-2 as a model system of colonocytes

Sarah DevrieseLien Van den BosscheSophie Van WeldenTom HolvoetIris PinheiroPieter HindryckxMartine De VosDebby Laukens

A1 Journal Article in HISTOCHEMISTRY AND CELL BIOLOGY

Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn’s disease-like ileitis

Lien Van den BosscheDaniel BorsboomSarah DevrieseSophie Van WeldenTom HolvoetLindsey DevisscherPieter HindryckxMartine De VosDebby Laukens

A1 Journal Article in LABORATORY INVESTIGATION

Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor

Tom HolvoetSarah DevrieseKarolien CastermansSandro BolandDirk LeysenYves-Paul VandewynckelLindsey DevisscherLien Van den BosscheSophie Van WeldenMelissa Dullaers et al.

A1 Journal Article in GASTROENTEROLOGY

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimantal colitis in mice

Lien Van den BosschePieter HindryckxLindsey DevisscherSarah DevrieseSophie Van WeldenTom HolvoetRamiro Vilchez VargasMarius VitalDietmar PieperJulie Vanden Bussche et al.

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice

Lien Van den BosschePieter HindryckxLindsey DevisscherSarah DevrieseSophie Van WeldenTom HolvoetRamiro Vilchez VargasMarius VitalDietmar H PieperJulie Vandenbussche et al.

A1 Journal Article in APPLIED AND ENVIRONMENTAL MICROBIOLOGY

2015

Fecal microbiota transplantation in irritable bowel syndrome with bloating : results from a prospective pilot study

Tom HolvoetJerina BoelensMarie JoossensJeroen RaesMartine De VosDanny De Looze

Soft ROCK inhibition prevents intestinal fibrosis in a murine colitis model

Tom HolvoetSarah DevrieseKarolien CastermansSandro BolandPieter HindryckxA BorinMartine De VosOlivier DefertDebby Laukens

Soft ROCK inhibition prevents intestinal fibrosis in a murine colitis model

Tom HolvoetSarah DevrieseKarolien CastermansSandro BolandPieter HindryckxArnaud BourinMartine De VosOlivier DefertDebby Laukens

Systematic review of guidelines for management of intermediate hepatocellular carcinoma using the Appraisal of Guidelines Research and Evaluation II instrument

Tom HolvoetSarah RaevensYves-Paul VandewynckelWim Van BiesenKaren GeboesHans Van Vlierberghe

A1 Journal Article in DIGESTIVE AND LIVER DISEASE

2014

Ferriprieve anemie : nieuwe ontwikkelingen in diagnose en behandeling

Tom HolvoetMartine De VosFilip Baert

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

Transplantatie van fecale microbiota : oude wijn in nieuwe zakken?

Tom HolvoetTom Van De WieleJerina BoelensJeroen RaesPieter HindryckxMartine De VosDanny De Looze

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

2012

Aanpak van diverticulitis: nieuwe richtlijnen

Tom HolvoetWim CeelenMartine De VosDanny De Looze

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

2011

Quantitative perfusion scintigraphy or anatomic segment method in lung cancer resection

Tom HolvoetJan Van MeerbeeckChristophe Van De WieleBihiyga SalhiEric Derom

A1 Journal Article in LUNG CANCER

2009

Muscle force and mass in patients with respiratory cancer: effects of radical treatment

Bihiyga SalhiTom HolvoetEric DeromJan Van Meerbeeck

Quantitative Perfusion Scintigraphy (QPS) or the Anatomic Segment Method (ASM) for estimating Postoperative Pulmonary Function (PF) in patients treated for non-small cel lung cancer (NSCLC): a retrospective comparison

Tom HolvoetEric DeromJan Van Meerbeeck